首页> 外国专利> Use of an alkylsulfone compound e.g. to treat or protect against toxicities associated with ionizing or non-ionizing radiations or administration of chemotherapeutic agents and to treat cancer

Use of an alkylsulfone compound e.g. to treat or protect against toxicities associated with ionizing or non-ionizing radiations or administration of chemotherapeutic agents and to treat cancer

机译:使用烷基砜化合物,例如治疗或预防与电离或非电离辐射或化疗药物相关的毒性,并治疗癌症

摘要

Use of an alkylsulfone compound (A) or its mono derivatives or dioxides for the manufacture of a drug to treat or protect against toxicities associated with ionizing or non-ionizing radiations or associated with administration of chemotherapeutic agents, protection or repair of healthy tissue in a patient affected by cancer receiving a therapy by radiation and/or chemotherapy with chemotherapeutic agents, or treatment or protection against toxicities associated with a therapy against cancer. Use of an alkylsulfone compound (A) of formula (R1-S(=O)-(CH2)n-N(R3)-C(=S)-N(R4)-(CH2)m-S(=O)-R2) (I) or its mono derivatives or dioxides of formulae (R1-S(=O)2-(CH2)n-N(R3)-C(=S)-N(R4)-(CH2)m-S(=O)-R2) (IIa), (R1-S(=O)-(CH2)n-N(R3)-C(=S)-N(R4)-(CH2)m-S(=O)2-R2) (IIb) and/or (R1-S(=O)2-(CH2)n-N(R3)-C(=S)-N(R4)-(CH2)m-S(=O)2-R2) (III) for the manufacture of a drug to treat or protect against toxicities associated with ionizing or non-ionizing radiations or associated with administration of chemotherapeutic agents, protection or repair of healthy tissue in a patient affected by cancer receiving a therapy by radiation and/or chemotherapy with chemotherapeutic agents, or treatment or protection against toxicities associated with a therapy against cancer. n, m : 1-12; and R1-R4H, 1-6C alkyl or aryl. An independent claim is also included for a composition (C) comprising (A) and chemotherapeutic agents, as combination product for simultaneous use, separated or continuous in time. ACTIVITY : Cytostatic. The ability of (A) to protect cells against toxicities was tested. The results showed that (A) protected 16-45% of the normal cells genotoxic and cytotoxic attacks. MECHANISM OF ACTION : None given.
机译:烷基砜化合物(A)或其单衍生物或二氧化物在制备药物中的用途,该药物用于治疗或预防与电离或非电离辐射有关的毒性或与化学疗法的给药有关,对健康组织的保护或修复。受癌症影响的患者接受放射治疗和/或化学疗法治疗,或接受针对癌症的治疗或针对毒性的治疗或防护。式(R1-S(= O)-(CH2)nN(R3)-C(= S)-N(R4)-(CH2)mS(= O)-R2)的烷基砜化合物(A)的使用( I)或其式(R1-S(= O)2-(CH2)nN(R3)-C(= S)-N(R4)-(CH2)mS(= O)-R2)的单衍生物或二氧化物(IIa),(R1-S(= O)-(CH2)nN(R3)-C(= S)-N(R4)-(CH2)mS(= O)2-R2)(IIb)和/或(R1-S(= O)2-(CH2)nN(R3)-C(= S)-N(R4)-(CH2)mS(= O)2-R2)(III)用于制造药物治疗或预防与电离或非电离辐射相关的毒性或与化学疗法的给药相关的毒性,在受癌症影响的患者中接受化学疗法的辐射和/或化学疗法或治疗或治疗的患者的健康组织的保护或修复预防与癌症疗法有关的毒性。 n,m:1-12; R 1 -R 4 H,1-6C烷基或芳基。还包括包含(A)和化学治疗剂的组合物(C)的独立权利要求,所述化学治疗剂作为同时使用,时间上分开或连续的组合产品。活动:细胞静息。测试了(A)保护细胞免受毒性的能力。结果表明(A)保护了正常细胞的16-45%的遗传毒性和细胞毒性攻击。作用机理:未给出。

著录项

  • 公开/公告号FR2881654A1

    专利类型

  • 公开/公告日2006-08-11

    原文格式PDF

  • 申请/专利权人 LMD;

    申请/专利号FR20050001216

  • 发明设计人 SAUNOIS ALEX;LE COZ PHILIPPE;

    申请日2005-02-07

  • 分类号A61K31/145;A61K31/337;A61K31/475;A61K31/664;A61P35;C07C335/06;

  • 国家 FR

  • 入库时间 2022-08-21 21:17:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号